Comparison Between IORT and Postoperative Radiotherapy in Breast Conserving Surgery
- Conditions
- Quality of Life
- Interventions
- Radiation: intraoperative radiotherapyRadiation: postoperative radiotherapy
- Registration Number
- NCT04789889
- Lead Sponsor
- Xiangyun Zong
- Brief Summary
To compare the satisfaction with conserved breast, acute and chronic postoperative complications and tumor control between intraoperative radiotherapy(IORT) and traditional postoperative radiotherapy following breast-conserving surgery (BCS).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- Female
- Target Recruitment
- 80
- Primary invasive breast cancer confirmed by pathology.
- Maximum tumor diameter ≤3.5cm.
- Clinical lymph nodes are negative.
- Single or multiple tumors are located on the same side of the nipple and in the same quadrant.
- ECOG status score ≤ 2.
- With informed Consents.
- Previous history of breast cancer or other malignant tumors.
- Inflammatory breast cancer; 3. Previous radiotherapy history.
- Other diseases affecting radiotherapy, such as connective tissue disease, heart disease, lung disease and so on.
- Patients who are not going to have the axillary lymph node surgery (including SLN and ALND) were excluded.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description IORT intraoperative radiotherapy intraoperative radiotherapy(IORT) in BCS. PORT postoperative radiotherapy traditional postoperative radiotherapy following BCS.
- Primary Outcome Measures
Name Time Method Rate of successful surgical procedure immediately after surgery the rate of successful breast conserving surgery
satisfaction with conserved breast 1 month after surgery the patients' satisfaction to postoperative breast including shape and feeling(Harvard/NSABP/RTOG BREAST COSMETIC SCALE: excellent, good, fair, poor)
- Secondary Outcome Measures
Name Time Method Rate of acute and chronic postoperative complications(CTCAE 3.0) 1-month, 6-month after surgery The incidence of adverse reactions at 1 and 6 months after operation
DFS 2-3 years after surgery long-term postoperative disease-free survival
OS 2-3 years after surgery long-term postoperative overall survival
Trial Locations
- Locations (1)
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
🇨🇳Shanghai, Shanghai, China